Business Context and Reporting Period
Company: MICROVISION, INC.
Filing Type: Form 10-Q (Unaudited)
Period Ended: June 30, 2002
Business Overview: Microvision develops retinal scanning displays, image capture devices, and electro-optical materials. Operations are divided into two segments: Microvision (retinal scanning) and Lumera Corporation (optical systems components, 76% owned). The company relies heavily on U.S. government development contracts and is in the early commercialization phase of its "Nomad" display and "Flic" barcode scanner.
Key Financial Metrics
| Metric (in thousands) | Six Months Ended June 30, 2002 | Six Months Ended June 30, 2001 |
|---|---|---|
| Revenue | $8,538 | $4,109 |
| Gross Margin | $4,532 (53.1%) | $1,466 (35.7%) |
| Net Loss | $(14,874) | $(18,786) |
| Net Loss Per Share (Basic/Diluted) | $(1.12) | $(1.57) |
| Cash Used in Operating Activities | $(15,131) | $(18,212) |
| Cash and Cash Equivalents (End of Period) | $11,120 | $8,811 |
| Total Liquidity (Cash + Investments) | $23,238 | $N/A |
| Total Debt (Current + Long-term) | $262 | $N/A |
Note: Total debt includes capital lease obligations and long-term debt. Liquidity includes cash, cash equivalents, and investment securities.
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 108% to $8.5 million for the six months ended June 30, 2002, compared to $4.1 million in the prior year. This was driven by an 85% reliance on U.S. government development contracts.
- Improved Loss Profile: Net loss decreased by 21% to $14.9 million, primarily due to reduced R&D expenses and lower non-cash compensation costs.
- Investment Impairment: The company recorded a $624,000 loss due to the total impairment of its investment in Gemfire Corporation following a recapitalization plan by Gemfire.
- Related Party Allowance: A $500,000 allowance for doubtful accounts was recorded against receivables from a senior officer due to concerns regarding repayment ability.
- Cost Structure: Cost of revenue increased 52% to $4.0 million, reflecting higher direct labor costs associated with increased contract volume. R&D expenses decreased 17% to $13.3 million, aided by the conclusion of a research agreement with CREE, Inc.
Guidance, Outlook, and Risks
Outlook and Liquidity: Management expects to incur significant losses through 2003. As of June 30, 2002, combined cash and investment securities totaled $23.2 million. Following a subsequent equity raise of $3.0 million in July 2002, management projects funds will meet cash requirements through the end of the first quarter of 2003. Additional financing will be required thereafter.
Operational Plans:
- Introduction of the "Flic" handheld barcode scanner in September 2002.
- Continued development of the "Nomad" retinal scanning display for defense and industrial sectors.
- Workforce reduction of approximately 7% in July 2002 to reduce operating costs, with $200,000 in termination benefits expected in Q3 2002.
Risks and Contingencies:
- Profitability: The company has an accumulated deficit of $115.8 million and no assurance of future profitability.
- Market Acceptance: Success depends on the commercial acceptance of retinal scanning and optical materials technologies, which face competition from established display manufacturers.
- Financing: Failure to secure additional capital could force significant operational reductions.
- Intellectual Property: Risks include potential patent infringement lawsuits and the inability to protect proprietary technology.
- Customer Concentration: Revenues are highly sensitive to U.S. government defense funding and the telecommunications sector downturn affecting Lumera.
Investor Verification Checklist
- Cash Runway: Verify the sufficiency of the $26.2 million liquidity position (including July 2002 raise) to fund operations through Q1 2003 and the timeline for the next capital raise.
- Contract Backlog: Confirm the $5.7 million backlog of development contracts and the timing of revenue recognition.
- Related Party Loans: Review the status of the $500,000 allowance for doubtful accounts regarding senior officer loans and potential recovery.
- Product Commercialization: Assess the progress of "Nomad" production costs versus revenue and the September 2002 launch of the "Flic" barcode scanner.
- Stock Dilution: Monitor the impact of outstanding options (5.6 million) and warrants (837k) on future share count and potential dilution from new financing.